CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV NASH-NAFLD
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
UEGW 2015     Banner2   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
In binge Britain, health chiefs say any alcohol is risky
01-08-2016
J&J signs deal with Chinese company for hepatitis B drug
01-07-2016
Dynavax's hep B vaccine meets goals in late-stage study
01-07-2016
Fibrin sealant patch provides better hemostasis during liver resection
01-06-2016
View Complete News Library
 
 
View all Congresses
 
 
 
  Line  
  Featured Abstracts          
 
Hepatitis C genotype 4: The past, present, and future
 
Synergistic activity of combined NS5A inhibitors
 
Genome-Wide Association Studies and Hepatitis C: Harvesting the Benefits of the Genomic Revolution
 
The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care
 
Potent Antiviral Activity of Direct-Acting Antivirals, ABT-493 and ABT-530, With 3-day Monotherapy for Hepatitis C Genotype 1 Infection
 
Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States
 
 
Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case-
 
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis
 
Role of occult hepatitis B virus infection in chronic hepatitis C
 
Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis
 
The why and wherefore of hepatic encephalopathy
 
In Patients with Cirrhosis, Driving Simulator Performance is Associated With Real-life Driving
 
 
Probiotics are Helpful in Hepatic Encephalopathy: A Meta-Analysis of Randomized Trials
 
Clinical science workshop: targeting the gut-liver-brain axis
 
Follow-up of patients with chronic hepatitis C and a sustained viral response
 
Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review
 
Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care
 
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
 
 
          View All Abstracts  
  Line  
                     
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
NASH/NAFLD
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.